Jana Medical Company (TADAWUL:9616)

Jana Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	64.34	61.36	43.05
Revenue Growth (YoY)	-	42.55%	-
Cost of Revenue	36.54	35.6	26.13
Gross Profit	27.79	25.76	16.92
Selling, General & Admin	10.7	10.05	8.77
Operating Expenses	11.82	13.23	9.41
Operating Income	15.97	12.53	7.5
Interest Expense	-7.79	-4.9	-1.52
Other Non Operating Income (Expenses)	-0.85	-1.09	-0.42
Pretax Income	7.33	6.55	5.56
Income Tax Expense	1.41	1.13	0.34
Net Income	5.92	5.41	5.22
Net Income to Common	5.92	5.41	5.22
Net Income Growth	-	3.65%	-
Shares Outstanding (Basic)	3	3	2
Shares Outstanding (Diluted)	3	3	2
Shares Change (YoY)	-	27.82%	-
EPS (Basic)	2.30	2.11	2.60
EPS (Diluted)	2.30	2.11	2.60
EPS Growth	-	-18.91%	-
Free Cash Flow	10.55	3.76	-36.77
Free Cash Flow Per Share	4.11	1.47	-18.29
Gross Margin	43.20%	41.98%	39.30%
Operating Margin	24.83%	20.42%	17.43%
Profit Margin	9.20%	8.82%	12.14%
Free Cash Flow Margin	16.40%	6.13%	-85.42%
EBITDA	16.13	12.66	7.56
EBITDA Margin	25.07%	20.64%	17.57%
D&A For EBITDA	0.16	0.14	0.06
EBIT	15.97	12.53	7.5
EBIT Margin	24.83%	20.42%	17.43%
Effective Tax Rate	19.27%	17.27%	6.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.